OverviewSuggest Edit

Sun BioPharma Inc. is a next-generation biopharmaceutical company developing disruptive therapeutics for serious unmet medical needs. The company’s initial programs are aimed at diseases of the pancreas, including pancreatic cancer and pancreatitis. Its lead product candidate is SBP-101, which is in Phase I clinical trial for the treatment of patients with pancreatic cancer.
TypePublic
Founded2011
HQWaconia, US
Websitesunbiopharma.com

Latest Updates

Employees (est.) (Feb 2019)5(-44%)
Revenue (FY, 2014)$148.6 K(-50%)
Share Price (Sept 2020)$3.2 (+4%)
Cybersecurity ratingAMore

Key People/Management at Sun BioPharma

Michael T. Cullen

Michael T. Cullen

Executive Chairman, Co-Founder, Chief Executive Officer
Thomas X. Neenan

Thomas X. Neenan

Co-Founder and Chief Scientific Officer
Suzanne Gagnon

Suzanne Gagnon

Chief Medical Officer
Susan Horvath

Susan Horvath

Vice President and Chief Financial Officer
Tammy Groene

Tammy Groene

Vice President of Operations
Robert Schemel

Robert Schemel

Director
Show more

Sun BioPharma Office Locations

Sun BioPharma has an office in Waconia
Waconia, US (HQ)
712 Vista Blvd #305
Show all (1)

Sun BioPharma Financials and Metrics

Sun BioPharma Revenue

Sun BioPharma's revenue was reported to be $148.64 k in FY, 2014
USD

Net income (Q2, 2020)

(419.0k)

EBIT (Q2, 2020)

(1.1m)

Market capitalization (16-Sept-2020)

31.3m

Closing stock price (16-Sept-2020)

3.2

Cash (30-Jun-2020)

2.3m

EV

29.1m
Sun BioPharma's current market capitalization is $31.3 m.
Annual
USDFY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Revenue

674.3k299.9k148.6k

Cost of goods sold

381.4k308.0k517.3k

Gross profit

292.8k(8.1k)(368.6k)

Gross profit Margin, %

43%(3%)(248%)
Quarterly
USDQ2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020

Revenue

63.0k42.5k40.2k36.2k34.8k51.8k36.8k

Cost of goods sold

69.2k72.6k79.8k130.3k124.8k123.2k119.6k

Gross profit

(6.2k)(30.1k)(39.6k)(94.1k)(90.0k)(71.4k)(82.8k)

Gross profit Margin, %

(10%)(71%)(99%)(260%)(259%)(138%)(225%)
Annual
USDFY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Cash

110.9k58.8k163.8k925.0k438.0k152.0k1.4m2.4m

Accounts Receivable

75.5k14.8k18.1k

Prepaid Expenses

389.0318.0382.074.0k118.0k195.0k110.0k283.0k

Current Assets

336.8k432.8k391.1k1.7m877.0k767.0k1.8m3.1m
Quarterly
Annual
USDFY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Net Income

247.4k(212.0k)(107.0k)(4.9m)(5.1m)(10.4m)(5.9m)(6.2m)

Depreciation and Amortization

5.6k8.8k9.6k

Accounts Payable

(10.6k)(24.1k)(3.7k)681.0k726.0k(319.0k)360.0k301.0k

Cash From Operating Activities

37.1k(35.4k)(11.5k)(3.9m)(2.4m)(3.4m)(2.4m)(2.7m)
USDFY, 2012

Debt/Equity

-0.4 x

Financial Leverage

-15 x
Show all financial metrics

Sun BioPharma Cybersecurity Score

Cybersecurity ratingPremium dataset

A

93/100

SecurityScorecard logo

Sun BioPharma Online and Social Media Presence

Embed Graph

Sun BioPharma News and Updates

Sun BioPharma, Inc. Announces Pricing of $10.5 Million Public Offering and Uplisting to the Nasdaq Capital Market

MINNEAPOLIS, Aug. 28, 2020 (GLOBE NEWSWIRE) -- Sun BioPharma, Inc. (OTCQB:SNBP Nasdaq:SNBP), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with pancreatic cancer, today announced the pricing of an underwritten public offering of 2,545,4…

Sun BioPharma, Inc. Provides Business Update and Reports Q2 2020 Financial Results

MINNEAPOLIS, Aug. 11, 2020 (GLOBE NEWSWIRE) -- Sun BioPharma, Inc. (OTCQB: SNBP), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with pancreatic cancer, today provides a business update and reports financial results for the quarter ended…

Sun BioPharma Provides Business Update and Reports Operating Results for FY2019

MINNEAPOLIS, March 24, 2020 (GLOBE NEWSWIRE) -- Sun BioPharma, Inc. (OTCQB: SNBP), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of pancreatic cancer, today provides a business update and reports financial results for the year ended December 31, 20…

Sun BioPharma, Inc. Initiates Search for CEO

Company founder Dr. Michael T. Cullen intends to continue to serve as Executive Chairman and will continue to serve as President and CEO until a successor is named Company founder Dr. Michael T. Cullen intends to continue to serve as Executive Chairman and will continue to serve as President and CEO…

Sun BioPharma, Inc. Provides a Business Update and Reports Q3 2019 Financial Results

MINNEAPOLIS, Nov. 13, 2019 (GLOBE NEWSWIRE) -- Sun BioPharma, Inc. (OTCQB: SNBP), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with pancreatic cancer, today provides a business update and reports financial results for the quarter ended…

Sun BioPharma, Inc. Provides a Business Update and Files Report for Q2 2019

MINNEAPOLIS, Aug. 13, 2019 (GLOBE NEWSWIRE) -- Sun BioPharma, Inc. (OTCQB: SNBP), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of pancreatic diseases, today provides a business update and reports financial results for the quarter ended June 30, 20…
Show more

Sun BioPharma Blogs

Sun BioPharma Frequently Asked Questions

  • When was Sun BioPharma founded?

    Sun BioPharma was founded in 2011.

  • Who are Sun BioPharma key executives?

    Sun BioPharma's key executives are Michael T. Cullen, Thomas X. Neenan and Suzanne Gagnon.

  • How many employees does Sun BioPharma have?

    Sun BioPharma has 5 employees.

  • Who are Sun BioPharma competitors?

    Competitors of Sun BioPharma include Athersys, Biogen and Reata Pharmaceuticals.

  • Where is Sun BioPharma headquarters?

    Sun BioPharma headquarters is located at 712 Vista Blvd #305, Waconia.

  • Where are Sun BioPharma offices?

    Sun BioPharma has an office in Waconia.

  • How many offices does Sun BioPharma have?

    Sun BioPharma has 1 office.